HIGHLIGHTS
- who: Christopher J, Cates and Toby J, Lasserson from the reviews, it has been demonstrated that use of LABAs alone may lead to higher mortality among asthma patientsThe aim of this systematic review was to compare occurrences of mortality and non-fatal severe adverse effects in clinical trials that randomized patients with asthma to make regular use of formoterol versus regular use of salmeterol, used in association with inhalatory corticoid as part of the randomized treatment. Eight studies were assessed in the systematic review, totaling, patients studied. The associations studied were formoterol + budesonide, salmeterol + fluticasone and formoterol . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.